HIV/SARS‐CoV‐2 coinfected patients in Istanbul, Turkey
Özlem Altuntaş Aydın, Hayat Kumbasar Karaosmanoğlu, Kadriye Kart Yaşar
Abstract
Highlights COVID‐19 coinfection has improved in HIV‐infected cases that use regular ART and where viral load is suppressed, and even in advanced HIV‐infected cases without treatment. Although the data are not yet sufficient, the impression is that the presence of comorbidities is an important factor in mortality in HIV/SARS‐CoV‐2 coinfected cases. Radiological imaging findings were observed in all HIV‐infected cases, even in the case with very low CD4 cell count. And, with immunochromatographic antibody tests, it was observed that antibody formation time was similar to uninfected individuals.
Topics & Concepts
CoinfectionVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Human immunodeficiency virus (HIV)Coronavirus disease 2019 (COVID-19)AntibodyMedicineViral load2019-20 coronavirus outbreakImmunologyInternal medicineOutbreakInfectious disease (medical specialty)DiseaseCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchCOVID-19 and healthcare impacts